Related Experiment Video

Updated: Jul 14, 2026

Experimental Human Pneumococcal Carriage
07:47

Experimental Human Pneumococcal Carriage

Published on: February 15, 2013

Effectiveness of pneumococcal conjugate vaccine in Greater Vancouver, Canada: 2004-2005

Gordean Bjornson1, David W Scheifele, Julie Bettinger

  • 1Vaccine Evaluation Center, BC Children's Hospital, Vancouver, B.C., Canada.

The Pediatric Infectious Disease Journal
|May 29, 2007
PubMed

Insights

Routine infant vaccination significantly reduced invasive pneumococcal disease in young children in Greater Vancouver. Disease rates in infants aged 6-23 months dropped substantially following vaccination programs.

Area of Science:

  • Pediatric Infectious Diseases
  • Vaccinology
  • Public Health Surveillance

Background:

  • Invasive pneumococcal infections pose a significant health burden in young children.
  • Pneumococcal conjugate vaccines (PCVs) are critical tools for disease prevention.
  • Effective surveillance is essential to monitor vaccine impact.

Purpose of the Study:

  • To evaluate the impact of routine infant vaccination on invasive pneumococcal infections (IP) in Greater Vancouver.
  • To assess changes in IP incidence rates among children aged 6-23 months.

Main Methods:

  • Population-based surveillance of invasive pneumococcal infections was conducted in Greater Vancouver.
  • Data were analyzed for children aged 6-23 months before and after the introduction of routine infant vaccination.
  • Disease rates were calculated, with a focus on vaccine serotypes.

Main Results:

  • A rapid and substantial decrease in IP incidence rates was observed in children aged 6-23 months.
  • Overall IP rates for this age group decreased by 84.6%.
  • Rates for vaccine serotypes specifically declined by 92.5%.

Conclusions:

  • Routine infant vaccination programs are highly effective in reducing invasive pneumococcal infections in young children.
  • Population-based surveillance demonstrates the significant public health impact of pneumococcal conjugate vaccines.
  • Vaccination is a key strategy for controlling pneumococcal disease burden in pediatric populations.

More Related Videos

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens08:47

Opsonophagocytic Killing Assay to Assess Immunological Responses Against Bacterial Pathogens

Published on: April 5, 2019

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Concept Videos

Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Vaccinations01:51

Vaccinations

Overview
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.